EndoGastric Solutions Announces New Sham-Controlled European Study Demonstrates Transoral Incisionless Fundoplication (TIF) Procedure As Effective Alternative For Daily PPI Treatment

EndoGastric Solutions (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), recently announced findings published online by Alimentary Pharmacology and Therapeutics from a new double-blind, sham-controlled, multi-center European study, which further confirmed the efficacy of the company’s Transoral Incisionless Fundoplication (TIF) procedure as a viable alternative to proton pump inhibitors (PPIs) to control chronic symptoms of GERD.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news